Fundraising Fox

Trapelo

Boston, US · Founded 2012 · Delaware corporation · 2 known investors

Trapelo Health operates Trapelo, a technology platform that gives oncologists, labs, and payers real-time, evidence-based clinical information to support precision medicine decisions in cancer care. The company also sponsors the Precision Medicine Podcast.

Founders & leadership

MP
Mark PortuNamed on SEC filing
KM
Kyle MortonNamed on SEC filing

Board

EHEric Hjerpe
Eric HjerpeBoard directorPartner at Kepha Partners

Investors · 2

Reported raises · per SEC filings

Form D private placements

$4.4M disclosed across 2 rounds · 2014–2017

$3.4MraisedJun 2017 · 5 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark PortuExecutive Officer, Director
  • Kyle MortonExecutive Officer, Director
  • Eric HjerpeDirector
Offering amount
$4.4M
Amount sold
$3.4M
Proceeds to insiders
$310K
First sale
Jun 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$990.9KraisedSep 2014 · 4 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric HjerpeDirector
  • Kyle MortonExecutive Officer, Director
Offering amount
$1.2M
Amount sold
$990.9K
Proceeds to insiders
$150K
First sale
Sep 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Trapelo do?
Trapelo Health operates Trapelo, a technology platform that gives oncologists, labs, and payers real-time, evidence-based clinical information to support precision medicine decisions in cancer care. The company also sponsors the Precision Medicine Podcast.
Who are Trapelo's investors?
Trapelo's investors include Beringea, Kepha Partners.
How much funding has Trapelo raised?
Trapelo has disclosed $4.4M raised across 2 rounds.
Where is Trapelo headquartered?
Trapelo is headquartered in Boston, US.